The International Imaging Conference (IIC) 2024, organised by ROAR B2B Ltd, brought together professionals, innovators, and stakeholders in imaging and healthcare technology. Following the acquisition of The Medical Imaging and Oncology Conventions from Prysm Group in 2021, ROAR B2B Ltd successfully transitioned the events into a rebranded and relaunched format as the International Imaging Congress in 2023. Moving from the Birmingham NEC to London Olympia, the International Imaging Congress is set to become Europe’s prominent medical imaging conference and exhibition, uniting leaders across the fields of radiology, pathology, and oncology. The conference aimed to foster collaboration and knowledge sharing among participants, focusing on the latest advancements in imaging technology and its implications for various sectors, including healthcare, radiology, and pathology. It featured a comprehensive agenda focused on the latest advancements and challenges in digital pathology and radiology. Kicked off with an introductory session, the first day’s session was followed by a panel discussion exploring the revolutionary potential of digital pathology. While radiology addressed the future of diagnostics, emphasising the need for adaptive healthcare delivery. Sessions included lessons on adopting cloud-based digital solutions and leveraging AI for detecting metastases. The day wrapped up with discussions on the ethical considerations surrounding AI in pathology and radiology. The second day commenced with a focus on the evolving NHS and the preservation of core values while embracing new technologies. Notable sessions included a panel on navigating the AI landscape responsibly, discussions on the societal impacts of AI in medical imaging, and a look into the role of community diagnostic centres in transforming healthcare. The day concluded with insights on optimising patient care through innovative imaging solutions, as well as discussions on the emerging concept of portfolio careers for clinicians in the industry.
The concept of “Minority Report Pathology” embodies the transformative potential of predictive analytics and advanced imaging technologies in healthcare, particularly in pathology. Inspired by the science fiction film “Minority Report” this session explored how similar innovations could revolutionise diagnostic practices in the medical field. With the unstoppable advancements in high-resolution imaging techniques, combined with sophisticated machine learning algorithms, they enable pathologists to not only detect diseases at an early stage but also delve deeper into the genomic intricacies of tissues and cells. These imaging modalities, which can visualise biological structures at unprecedented detail, allow for the identification of specific genomic markers and mutations associated with various diseases. By integrating detailed imaging data with genomic information, healthcare professionals can gain a more comprehensive understanding of disease mechanisms, leading to more personalised and effective treatment strategies. This shift towards a holistic approach emphasises not just early detection but also the capacity to tailor interventions based on individual genetic profiles. There is a need for careful and diplomatic approach as we navigate the complexities introduced by these advancements. The ethical implications of high imaging and genomic analysis, particularly concerning data privacy, its uses and the responsibility of healthcare providers to use predictive diagnostics ethically, should be highlighted. As well as the balance between harnessing the power of advanced technologies and maintaining transparency and consent. It certainly will unleash the potential to transform not only how we diagnose but also how we manage and prevent diseases, ultimately reshaping the future of healthcare.
The session on the “Future of Remote Scanning” was particularly groundbreaking. It focused on the potential of remote scanning to democratise radiology imaging, making it accessible across various healthcare settings. Few companies collaborating as aggregators to establish a central repository, designed to provide a comprehensive and unified source of data for systems like those developed by Siemens. This evolving model aims to enhance efficiency and accessibility, opening up opportunities for smaller healthcare facilities to access advanced scanning technology without the need for onsite, high-cost infrastructure. The interest will be in how this ecosystem could see the advancement of efficient and scalable scanning solutions, within agreed regulatory frameworks. Another key session was the “Women in the Sector” panel discussion, which addressed the current state of gender diversity within radiology and pathology. The atmosphere was generally positive, with panelists expressing enthusiasm about the strides being made; however, they acknowledged that the proportion of women in leadership roles remains imbalanced. While progress has been made, the session highlighted the need for continued efforts to promote gender parity, mentorship, and opportunities for women to ascend into influential positions within the industry. The question remains, is now the time for a new strategy?
A Growing Need for Secure and Scalable Solutions
The market for healthcare technology and digital transformation in radiology and pathology is still growing, but it’s also becoming more specialised. There’s a shift toward a more targeted use of sub-tech solutions, where categorisation and application of technology are becoming clearer and more precise. Companies are increasingly focusing on niche areas, such as advanced imaging software, data analytics platforms, and solutions for remote diagnosis, to offer tailored solutions for specific needs. This trend indicates a maturing market where the focus is not just on innovation but on creating sustainable, modular products that cater to precise industry requirements. For instance, the integration of AI and advanced analytics into remote scanning is becoming a key differentiator for companies in this space. Organisations are beginning to realise that simply having the technology is not enough; they must also provide reliable, secure, and user-friendly solutions that can be customised to fit different clinical environments. This evolution aligns with our approach, where we prioritise modularity and adaptability in our tech solutions. One key insight from the event was the growing need for secure, scalable, and yet transparent and interoperable solutions in healthcare technology. With the move towards remote scanning and the centralisation of radiology data, concerns over data security, privacy, and interoperability were front and centre. The potential benefits of democratising radiology are immense, ensuring compliance with regulations such as GDPR and maintaining the integrity of data flows are critical challenges.
The products and solutions displayed at the event were undoubtedly up-to-date, reflecting the current standards and capabilities in healthcare tech. However, exhibitors and attendees alike noted that the very latest, cutting-edge innovations were not as prominently featured as expected. This suggests that while the market is moving forward, there may still be a gap between developing advanced technologies and bringing them to public showcases. By staying ahead of these trends and integrating our solutions into the rapidly evolving market, we aim to bridge the gap and bring the latest tech innovations into public awareness and adoption. Our modular and flexible approach allows us to create solutions that not only meet current demands but anticipate future needs, ensuring we remain at the forefront of industry developments. The conference offered valuable insights into the current state and future trends of healthcare technology, particularly in radiology and pathology. Despite the low-key atmosphere compared to previous years, the event provided opportunities for meaningful networking and knowledge exchange, setting the stage for future growth and collaboration in the sector. It was particularly valuable in aligning the focus on integrating technology and advanced analytics into healthcare. There are still avenues for explorations in these areas, presenting opportunities to collaborate and be at the forefront of biotech innovations.
About The Author
